“CIPN is a common toxicity associated with the use of chemotherapy (CT) agents such as platinums, taxanes and vinca alkaloids. Patients (pts) may suffer from pain that adversely affects their quality of life, regardless of their disease trajectory.
Preclinical research has shown CBs to be effective in preventing CIPN.
CBs can be beneficial for cancer pain, although their specific benefit in pts with CIPN remains unknown.
Treatment with CBs appears to benefit some pts with CIPN.
Further research is needed to explore the optimal use of CBs in pts with CIPN.”
https://www.ncbi.nlm.nih.gov/pubmed/27962037
